On November 12, 2021, we consummated the initial public offering of 20,010,000 units. The units sold in the initial public offering were sold at an offering price of $10.00 per unit, generating gross proceeds of $200,100,000. Mizuho Securities USA LLC acted as book-running manager. The securities in the offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-260199). The Securities and Exchange Commission declared the registration statement effective on November 8, 2021.
Simultaneous with the consummation of the initial public offering, the Company consummated the private placement of an aggregate of 10,399,000 private placement warrants at a price of $1.00 per private placement warrant, generating total proceeds of $10,399,000. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
On November 9, 2021, the underwriter exercised the over-allotment option to purchase an additional of 2,610,000 units at the initial public offering price at $10.00 per unit and we consummated the sale of such units on November 12, 2021, generating additional gross proceeds of $26,100,000.
Of the gross proceeds received from the initial public offering and sale of the private placement warrants, including the over-allotment exercise, $204,102,000 was placed in the trust account.
Use of Proceeds
On November 12, 2021, we consummated the initial public offering of 20,010,000 units, which includes the exercise by the underwriter of its over-allotment option in the amount of 2,610,000 units, at a price of $10.00 per unit, generating aggregate gross proceeds of $204,102,000. Simultaneous with the consummation of the initial public offering, the we consummated the private placement sale to our Sponsor of an aggregate of 10,399,000 private placement warrants, each private placement warrant exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per private placement warrant, generating total proceeds of $10,399,000.
Following the initial public offering and the sale of the private placement warrants, a total of $204,102,000 was placed in the trust account. We incurred $11,816,317 in offering costs, consisting of $4,002,000 of underwriting discount, $7,003,500 of deferred underwriting discount, and $810,817 of other offering costs.
At December 31, 2022, we had cash and marketable securities held in the trust account of $207,176,794 net of redemptions. We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account (excluding deferred underwriting commissions and less taxes payable) to complete our initial business combination. We may withdraw interest from the trust account to pay our taxes. To the extent that our equity or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
At December 31, 2022, we had cash of $144,455 held outside of the trust account. We intend to use the funds held outside of the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate, and complete a business combination.
In order to fund working capital deficiencies or finance transaction costs in connection with an initial business combination, our Sponsor, officers, directors, or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts, but no proceeds from our trust account would be used for such repayment. Up to $1,000,000 of such loans may be convertible into private placement warrants of the post business combination entity at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the private warrants.
Prior to the completion of the initial business combination, we do not expect to seek loans from parties other than our Sponsor or an affiliate of our Sponsor as we does not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. If we are unable to complete our initial business combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account.